Drugs News and Research

RSS

Americans will spend a larger share of their lifetime taking prescription drugs, research finds

An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by Jessica Ho, associate professor of sociology and demography at Penn State.

12 Oct 2023

Mount Sinai researchers receive NIH grant to compare new treatment options for sickle cell disease

The Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.

12 Oct 2023

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

A new study will combine an Alzheimer's medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.

12 Oct 2023

KFF Health News' 'What the Health?': Health funding in question in a speaker-less Congress

As House Republicans struggle — again — to decide who will lead them, the clock is ticking on a short-term spending bill that keeps the federal government running only until mid-November.

12 Oct 2023

Researchers call for urgent improvement in pain management for inflammatory arthritis patients

Researchers from Keele University's School of Medicine have found that analgesic medicines - commonly known as "painkillers" - are widely prescribed to people with inflammatory arthritis across England despite little research evidence that they improve pain for these patients, and studies showing they can cause serious side-effects.

12 Oct 2023

Does your gut microbiome play a role in therapeutic outcomes?

The role of the gut microbiome and its metabolites in altering the therapeutic outcomes

12 Oct 2023

Accelerating drug discovery with analytical R&D solutions

In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 12 Oct 2023

California bans controversial ‘excited delirium’ diagnosis

California is the first state to ban doctors and medical examiners from attributing deaths to the controversial diagnosis known as "excited delirium," which a human rights activist hailed as a "watershed moment" that could make it harder for police to justify excessive force.

12 Oct 2023

PrEP, a key HIV prevention tool, isn’t reaching Black women

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV.

12 Oct 2023

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

12 Oct 2023

Genetic causes of Raynaud’s phenomenon identified

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.

12 Oct 2023

New drug molecule restores lost nerve-muscle connections, enhances strength

A small molecule previously shown to enhance strength in injured or old laboratory mice does so by restoring lost connections between nerves and muscle fibers, Stanford Medicine researchers have found.

11 Oct 2023

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

In 2023, life expectancy in Korea will be 83.6 years, the third highest among OECD countries, and it is steadily increasing every year.

11 Oct 2023

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year.

11 Oct 2023

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options.

11 Oct 2023

Scientists identify nearly a dozen genes responsible for coronary artery calcification

An international team of scientists has identified nearly a dozen genes that contribute to calcium buildup in our coronary arteries that can lead to life-threatening coronary artery disease, a condition responsible for up to one in four deaths in the United States.

11 Oct 2023

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

The intricate interactions between gut microbiota and drugs.

11 Oct 2023

Fragile X syndrome may be unfolding in brain cells even before birth

Fragile X syndrome, the most common form of inherited intellectual disability, may be unfolding in brain cells even before birth, despite typically going undiagnosed until age 3 or later.

10 Oct 2023

Is night shift work rewiring our appetite and driving weight gain?

Bristol University scientists reveal that night shift work disrupts the body's circadian rhythm, altering appetite-regulating hormones and leading to weight gain. The study, providing insights into metabolic health, may aid in developing treatments for eating disorders and obesity.

10 Oct 2023

IU Cancer Center awarded grant to train next generation of cancer drug discovery researchers

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and development researchers.

10 Oct 2023

Drugs News and Research

Americans will spend a larger share of their lifetime taking prescription drugs, research finds

Mount Sinai researchers receive NIH grant to compare new treatment options for sickle cell disease

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

KFF Health News' 'What the Health?': Health funding in question in a speaker-less Congress

Researchers call for urgent improvement in pain management for inflammatory arthritis patients

Does your gut microbiome play a role in therapeutic outcomes?

Accelerating drug discovery with analytical R&D solutions

California bans controversial ‘excited delirium’ diagnosis

PrEP, a key HIV prevention tool, isn’t reaching Black women

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Genetic causes of Raynaud’s phenomenon identified

New drug molecule restores lost nerve-muscle connections, enhances strength

New glutamine sensor could revolutionize early diagnosis and treatment of geriatric diseases

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Scientists identify nearly a dozen genes responsible for coronary artery calcification

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

Fragile X syndrome may be unfolding in brain cells even before birth

Is night shift work rewiring our appetite and driving weight gain?

IU Cancer Center awarded grant to train next generation of cancer drug discovery researchers

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News